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There is evidence that chronic ethanol treatment (CET) disrupts
the biological rhythms of various brain functions and behaviors.
Because the suprachiasmatic nucleus (SCN) is widely recog-
nized as the dominant pacemaker of the circadian system, we
have examined the effects of CET and withdrawal on the main
morphological features and chemoarchitecture of this hypotha-
lamic nucleus. Groups of rats ethanol-treated for 6 and 12
months were compared with withdrawn rats (ethanol-treated
for 6 months and then switched to a normal diet for an addi-
tional 6 months) and with groups of age-matched control and
pair-fed control rats. The volume and the total number of
neurons of the SCN were estimated from conventionally
stained material, whereas the total number of astrocytes and of
neurons containing vasopressin (AVP), vasoactive intestinal
polypeptide (VIP), gastrin-releasing peptide (GRP), and soma-
tostatin (SS) were estimated from immunostained sections. The
estimates were obtained using unbiased stereological meth-
ods, based on Cavalieri’s principle and the optical fractionator.
The volume of the SCN and the total number of SCN neurons
and astrocytes did not vary among groups. We found, however,
that CET induced a signiﬁcant reduction in the total number of
AVP-, VIP-, GRP-, and SS-containing neurons. Withdrawal
from alcohol did not reduce but rather augmented the loss of
VIP- and GRP-immunoreactive neurons. The CET-induced
neurochemical alterations seem to result from a decrease in
neuropeptide synthesis, as revealed by the reduction in AVP
and VIP mRNA levels demonstrated by in situ hybridization with
radioactively labeled 48-mer AVP and 30-mer VIP probes. It is
thus possible to conclude that the irreversible CET-induced
changes in the neurochemistry of the SCN might underpin the
disturbances in circadian rhythms observed after long-term
alcohol consumption.
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Despite the widely accepted view that chronic alcohol abuse
affects virtually the entire CNS, in the past decades the main
research focus has been on alterations that might explain the
alcohol-induced cognitive dysfunctions. Notwithstanding this fact,
there is abundant clinical and experimental data indicating that
chronic ethanol treatment (CET) is associated with endocrine
dysfunction (Morgan, 1982). Studies performed in humans are not
conclusive regarding the severity of these disturbances, and in this
respect investigations carried out in rodents have provided a
major contribution to the understanding of the effects of alcohol
on the functioning of the nervous and endocrine systems. In these
species, CET is known to depress the activity of the systems
involved in the production of thyroid hormones (Mason et al.,
1992) and gonadal steroids (Cicero et al., 1979; Rivier et al., 1992)
and to activate the hypothalamic-pituitary-adrenal axis (Tabakoff
et al., 1978; Rivier et al., 1990; Rivier, 1996). Yet, despite exten-
sive knowledge concerning hormonal disturbances associated with
excess alcohol, it remains unclear whether these alterations result
from direct effects of alcohol at the level of the hypothalamus, the
pituitary, or the peripheral endocrine glands.
Some of the functions that are modulated by the neuroendo-
crine system and are known to be altered by CET display (under
normal conditions) typical biological rhythms, which are them-
selves affected by exposure to alcohol. For example, the circadian
variations in plasma corticosterone concentration (Tabakoff et al.,
1978) and the cyclic pattern of gonadotrophin production in
females (Sundberg et al., 1987; Alfonso et al., 1993) are both
abolished as a consequence of CET. In addition, excess alcohol
affects the biological rhythms inherent in other behaviors and
functions, leading, for example, to disruption of circadian sleep
rhythms (Gilliam and Collins, 1983; Hilakivi et al., 1987), to
interference with spontaneous locomotor activity (Deimling and
Schnell, 1980), and to changes in patterns of feeding and drinking
(Miller, 1992).
There is strong evidence that the establishment of biological
rhythms and the entrainment of rhythms to environmental light/
dark cycles are governed by the suprachiasmatic nucleus (SCN)
(Klein et al., 1991). The SCN of the rat is a relatively small nucleus
that contains 17,000 parvocellular neurons of uniform size (Ma-
deira et al., 1995). These neurons, however, are not distributed
evenly throughout the nucleus but display regional differences in
packing density and orientation (van den Pol, 1980), which have
led to the recognition of distinct anatomical subdivisions within
the SCN, the dorsomedial and the ventrolateral, which also differ
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Morin, 1994) and the peptides they produce (Card and Moore,
1984; van den Pol and Tsujimoto, 1985). Neurons synthesizing
vasopressin (AVP) and somatostatin (SS) are concentrated in the
dorsomedial subdivision, whereas those producing vasoactive in-
testinal polypeptide (VIP) and gastrin-releasing peptide (GRP)
are located in the ventrolateral subdivision. The neurons of the
latter subdivision receive the bulk of afferents to the SCN and
together with AVP-producing neurons give rise to efferents to
extra- and intrahypothalamic target areas through which the SCN
inﬂuences various functions and behaviors.
Previous studies have shown that experimentally induced le-
sions of the SCN or bilateral ablations of the SCN abolish the
rhythmicity of corticosterone production, sleep–wakefulness,
feeding patterns, and locomotor activity, and completely eliminate
the phasic release of gonadotrophins (for reviews, see Rusak and
Zucker, 1979; Moore, 1983). Because the effects of alcohol expo-
sure on the rhythmic patterns of certain functions and behaviors
are identical to those resulting from lesions of the SCN, we have
sought to establish whether the alterations induced by CET might
be explained by changes in the SCN, such as speciﬁc alterations of
its constituent neuronal and/or glial subpopulations. Using unbi-
ased stereological techniques, we have estimated the volume and
the total cell number of the SCN in rats exposed to alcohol over
periods of 6 and 12 months. Because SCN astrocytes share many
morphological (van den Pol, 1980) and functional (van den Pol et
al., 1992; Prosser et al., 1994) features with SCN neurons, we have
also separately estimated the total number of cells containing glial
ﬁbrillary acidic protein (GFAP). In addition, to further charac-
terize the effects of CET on the cellular and molecular mecha-
nisms underlying the expression of circadian rhythms, we have
also independently estimated, using the same stereological tech-
niques, the total number of the major neuronal subpopulations in
the SCN, i.e., the AVP-, VIP-, GRP-, and SS-immunoreactive
neurons. Because exposure to alcohol might interfere differen-
tially with the synthesis, release, and metabolism of different
peptides (Paula-Barbosa and Tavares, 1985; McLane, 1987; Ruela
et al., 1994), we have also examined the consequences of CET on
the expression of mRNA encoding AVP and VIP in the SCN by
in situ hybridization. Finally, because there is evidence that the
alcohol-induced disruption of the biological rhythms of certain
functions and behaviors are normalized after abstinence from
alcohol (Tabakoff et al., 1978; Anderson et al., 1985; Adinoff et al.,
1990; Dees and Skelley, 1990), we have extended this study to the
SCN of CET rats withdrawn from alcohol for 6 months.
A preliminary report of this work has been published previously
in abstract form (Madeira et al., 1994).
MATERIALS AND METHODS
Animals and treatments
Male Wistar rats derived from the colony of the Gulbenkian Institute of
Science (Oeiras, Portugal) were maintained throughout the experiment
under standard laboratory conditions: 12 hr light/dark cycle (lights on at
8:00 A.M.) and temperature of 228C. Food pellets and water were
available ad libitum until the rats were 2 months old. At this age they were
placed in individual cages, assigned to four experimental groups, and
treated as follows.
Ethanol-treated subgroups. Rats were given an aqueous ethanol solution
as their only available liquid source for 6 or 12 months, i.e., until the age
of 8 or 14 months. The ethanol concentration started with a 5% (v/v)
solution and was increased progressively by 1% per day to a ﬁnal 20%
(v/v) solution 2 weeks later. Food was freely available throughout the
treatment period. The amounts of food and ethanol solution consumed
were measured every other day.
Withdrawal group. Rats were ethanol-treated for 6 months and then
switched to tap water for an additional 6 months. The shift from ethanol
treatment to water intake was performed gradually over a 2 week period
by progressive reduction of the ethanol concentration in the drinking
solution by 1% per day. Food pellets were freely available throughout the
experiment.
Pair-fed control subgroups. Animals with free access to water were given
for 6 or 12 months an amount of dry food that was equivalent to the mean
amount of food consumed by animals of the ethanol-treated group plus
an additional quantity that provided a caloric intake equal to that sup-
plied by the quantity of ethanol solution drunk by the ethanol-treated
rats. The additional number of pellets was calculated, taking into account
the caloric value of ethanol (1 gm 5 7 Kcal) and the mean volume of
alcohol consumed by ethanol-treated rats (10 ml ethanol 5 7.9 gm). This
nutritional control was chosen because in a previous study (Madeira et
al., 1993) we demonstrated that it was adequate to overcome the hyper-
osmolality derived from the addition of sucrose or dextrin-maltose to the
drinking solution, which is commonly used in alcohol research (Lieber
and DeCarli, 1982).
Control subgroups. These animals had free access to standard labora-
tory diet and tap water for the duration of the study.
In all groups, liquids consumed were supplemented with 300 mg/100 ml
of vitamins (Vitamin Diet Fortiﬁcation Mixture, ICN Biomedicals, Cleve-
land, OH) and 500 mg/100 ml of minerals (Salt Mixture, ICN Biomedi-
cals). Body weights were recorded every 15th day and on the day the
animals were killed.
The material used in this investigation was collected between 9:00 A.M.
and 10:00 A.M. from 95 animals. The hypothalami from 42 animals, ages
8 months (18) and 14 months (24), were embedded in glycolmethacrylate
and used for the estimation of the volume of and total cell numbers in the
SCN. Thirty-six rats, aged 14 months, were used for the immunocyto-
chemical detection of the AVP-, VIP-, GRP-, and SS-containing neurons
in the SCN. Ten 14-month-old rats were used for the identiﬁcation and
enumeration of SCN astrocytes by immunocytochemical detection of
GFAP. Finally, seven animals, aged 14 months, were used for the analysis
of AVP and VIP mRNA expression by in situ hybridization.
Blood alcohol determinations. Blood alcohol concentrations were mea-
sured in all ethanol-treated rats used in this experiment. Blood samples
(500 ml) were collected in the morning (8:00 A.M.) and evening (6:00
P.M.) from the dorsal vein of the tail after 4, 6, and 14 months of









8 months old 570 (0.12) 443 (0.09) 432 (0.06) –
14 months old 635 (0.08) 503 (0.06) 505 (0.15) 586 (0.11)
Brain weight
8 months old 1.54 (0.02) 1.51 (0.04) 1.49 (0.08) –
14 months old 1.63 (0.08) 1.54 (0.03) 1.54 (0.07) 1.57 (0.09)
Data are expressed as mean (CV). Results of post hoc linear polynomial contrasts applied to mean body weights of 8-month-old rats: C vs ET, p , 5 3 10
24; C vs PFC, p ,
0.005. Results of post hoc linear polynomial contrasts applied to mean body weights of 14-month-old rats: C vs PFC, C vs ET, ET vs W, p , 5 3 10
24; PFC vs W, p , 0.02.
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enzymatic assay kit (Boehringer Mannheim, Mannheim, Germany).
Hormone determinations. Corticosterone assays were carried out in
14-month-old control, ethanol-treated, and ethanol-withdrawn rats 15 d
before they were killed. Blood samples (500 ml) were taken from the
dorsal vein of the tail at 2:00 A.M., 8:00 A.M., 2:00 P.M., and 8:00 P.M.
The blood samples were placed in Eppendorf tubes, and serum was
separated by centrifugation and preserved at 2208C until the time of
assay. Corticosterone levels were determined by radioimmunoassay using
a kit supplied by ICN Biomedicals (Costa Mesa, CA). All samples were
assayed in a single run, the intra-assay coefﬁcient of variation being ;5%.
Tissue preparation
Conventional histological procedures. Animals were anesthetized with
ether and transcardially perfused with a ﬁxative solution containing 1%
paraformaldehyde and 1% glutaraldehyde in 0.12 M phosphate buffer at
pH 7.2. The brains were removed from the skulls, weighed, and post-ﬁxed
for 15 d in fresh ﬁxative. After removal of the frontal and occipital poles,
the blocks of tissue containing both the right and left hypothalami were
dehydrated through a graded series of ethanol solutions and embedded in
glycolmethacrylate (hydroxyethylmethacrylate; Technovit 7100, Kulzer
and Co., Wehrheim, Germany), as described in detail elsewhere (West et
al., 1991). These blocks were then sectioned in the coronal plane at a
nominal thickness of 40 mm using a Jung Multicut microtome. The
sections were collected, mounted serially, and stained with a Giemsa
solution modiﬁed for use in glycolmethacrylate-embedded material
(West et al., 1991).
Immunohistochemical procedures. The animals were anesthetized by
intraperitoneal injection of a solution of 2.5% sodium pentobarbital in
physiological saline (2 ml/kg body weight) and killed by transcardiac
perfusion of ﬁxative solution. For immunostaining with GFAP, the ﬁxa-
tive used contained 4% paraformaldehyde and 0.1% glutaraldehyde in
0.12 M phosphate buffer at pH 7.6. For immunostaining with antiserum
against AVP, VIP, GRP, and SS, rats were perfused with a solution
containing 4% paraformaldehyde in phosphate buffer at pH 7.6. The
brains were removed and immersed for 24 hr in the same ﬁxative solution.
After the frontal and occipital poles were trimmed away, blocks contain-
ing the right and left hypothalami were mounted on a vibratome and
serially sectioned at a nominal thickness of 30 mm in the coronal plane.
Sections were collected in PBS, washed twice, and then treated with 3%
H2O2 for 10 min to inactivate endogenous peroxidase.
For GFAP immunohistochemistry, all sections containing the SCN
were incubated with a polyclonal rabbit antibody (Dakopatts, Glostrup,
Denmark) diluted 1:250 in PBS containing 1% Triton X-100 for 48 hr at
48C. After three washes in PBS, sections were incubated with biotinylated
goat anti-rabbit IgG (Vector Laboratories, Burlingame, CA) at a dilution
of 1:400 for 2 hr and with avidin–biotin peroxidase complex (Vectastain
Elite ABC Kit, Vector Laboratories) at a dilution of 1:800 for 2 hr at
room temperature. Peroxidase was visualized using 0.05% diaminoben-
zidine (DAB) (Sigma, St. Louis, MO) as chromogen and 0.01% H2O2 in
PBS as substrate, for 10 min. During this step, sections were incubated
with 0.2% nickel ammonium sulfate to intensify the DAB reaction prod-
uct. To enable precise visualization of the boundaries of the SCN,
sections were counterstained with cresyl violet.
For peptide immunostaining, alternate sections were collected sepa-
rately in PBS. From the two independent sets of sections thus obtained
from each brain, one was used for AVP or VIP immunostaining and the
other for GRP or SS immunostaining. Antisera against AVP, VIP, and
GRP were a gift of Dr. Ruud Buijs (The Netherlands Institute for Brain
Research, Amsterdam) and the antiserum against SS was purchased from
Peninsula Laboratories (Belmont, CA). The antisera were used at the
following dilutions: AVP, 1:5000; VIP, 1:1000; GRP, 1:5000; SS, 1:4000.
Sections were incubated overnight with the primary antiserum at 48C.
Biotinylated goat anti-rabbit antibody (Vector Laboratories) at 1:400
dilution was used as the secondary antibody. Sections were treated with
avidin–biotin peroxidase complex (Vector Laboratories) diluted 1:800. In
these two last steps, the incubation was carried out for at least 1 hr at
room temperature. After treatment with the peroxidase complex, sections
were incubated for 10 min in DAB (Sigma), to which 0.01% H2O2 was
added. Sections were rinsed with PBS for at least 30 min between each
step. Tissue penetration was increased by the inclusion of 1% Triton
X-100 in all immunoreactions and by sonication. To intensify the DAB
reaction product, sections were incubated for 10 min and during the DAB
step with 0.2% nickel ammonium sulfate. All procedures were performed
on a rocking table. Stained sections were mounted on gelatin-coated
slides and air-dried. They were then dehydrated and coverslipped using
Eukitt. The immunohistochemical staining of the sections from all groups
analyzed was performed in parallel at the same time. The same procedure
was followed for control sections, which were incubated without primary
antiserum; no immunostaining was observed in these sections.
AVP and VIP mRNA in situ hybridization histochemistry. The rats were
killed by decapitation. The entire brain was rapidly removed and imme-
diately frozen in dry ice. The brain was then mounted in a Cryostat, and
12-mm-thick sections containing both the right and left hypothalami were
cut in the coronal plane. Sections were then thaw-mounted onto gelatin-
coated slides, warmed to 378C for ;1 min, and stored at 2708C until use.
Before hybridization, the slides were ﬁxed in 4% formaldehyde in 0.12 M
PBS at pH 7.4 for 5 min at room temperature, rinsed twice with PBS,
incubated in 0.25% acetic anhydride in 0.1 M triethanolamine/0.9% NaCl
at pH 8 for 10 min at room temperature, and passed through a graded
series of ethanols and chloroform before being air-dried. Hybridizations
were carried out under steady-state conditions overnight at 378C with
0.5–1.0 3 10
6 dpm of AVP and VIP probes in 25 ml of a hybridization
buffer described in detail elsewhere (Przewlocki et al., 1992). The AVP
probe (MWG-Biotech, Ebersberg, Germany) was 48 bases long and
complementary to bases coding for the 16 terminal amino acids of the
glycoprotein sequence (Patchev et al., 1995). The VIP probe (MWG-
Biotech) was 30 bases long and complementary to the 10 terminal amino
acids of the glycoprotein (Montagne et al., 1995). The probes were
labeled by
35S-dATP (1200 Ci/mmol; DuPont NEN, Bad Homburg,
Germany) and terminal deoxynucleotidyl transferase. After hybridiza-
tion, nonspeciﬁcally bound probe was removed by four washes of 15 min
each in a solution of 50% formamide/4 3 sodium chloride/sodium citrate
buffer (SCC 5 0.15 M NaCl and 0.015 M sodium citrate, pH 7.2) at 408C,
followed by two rinses in 13 SSC at room temperature. The slides were
then dehydrated through graded ethanols containing 300 mM ammonium
acetate and ﬁnally in absolute ethanol. The autoradiographic images of
the hybridization signals were generated by apposition of the air-dried,
slide-mounted sections to Hyperﬁlm b-max (Amersham International,
Little Chalfont, UK) in standard x-ray cassettes for a period of 7 hr for
AVP and 7 d for VIP; radioactive standards were run alongside.
Stereology
Volume estimation. The volume of the SCN was estimated by using the
principle of Cavalieri (1966). From each methacrylate-embedded hypo-
thalamus, all sections containing the SCN were used (Fig. 1A). In each
section, the cross-sectional area of the SCN was estimated by point
counting (Gundersen et al., 1988; Madeira et al., 1995) at a ﬁnal magni-
ﬁcation of 3313, using a grid of test points (Grid Stereological Package,
Olympus Danmark A/S, Glostrup, Denmark) in which the interpoint
distance was 31 mm. The volume of the SCN was calculated from the total
number of points that fell on the nucleus and the distance between the
systematically sampled sections (Gundersen and Jensen, 1987; Madeira et
al., 1995). Estimates were performed bilaterally, but because no right/left
asymmetry was found, data were pooled from the two sides for each
animal. The tissue shrinkage factor was not calculated, because it is
generally accepted that tissue embedded in glycolmethacrylate undergoes
virtually no shrinkage (Brængaard et al., 1990).
Estimation of the total number of neurons. Total neuronal numbers were
estimated using the optical fractionator (West et al., 1991; Madeira et al.,
1995). Microglia and oligodendrocytes, characterized by small and opti-
cally dense cell bodies, and astrocytes were not included in the estimates
(Fig. 1B). To evaluate whether changes in the number of astrocytes,
which are difﬁcult to discriminate from neurons on the basis of cell size
and shape at this level of resolution (van den Pol, 1980; Madeira et al.,
1995), could interfere with the estimates of neuronal numbers, the total
number of astrocytes was estimated separately in GFAP-immunostained
material (Fig. 1C,D). For the estimation of the total number of SCN cells,
all sections containing the SCN were used, which provided an average of
18 sections per nucleus. The ﬁelds of view were systematically sampled
using a step size of 0.132 mm along the x axis and 0.144 mm along the y
axis; the disector used had a counting frame area of 496 mm
2 at the tissue
level and a ﬁxed depth of 10 mm. Neurons were counted only when the
nucleus was unambiguously apparent. An average of 130 neurons per
nucleus were counted using the above-described sampling scheme, which
can be summarized as follows. The section sampling fraction, ssf, was 1,
the area sampling fraction, asf, was 0.0261, and the thickness sampling
fraction, tsf, was 0.29. The ﬁnal magniﬁcation at the level of the monitor
was 28003. Cell counting was carried out using an Olympus Video
Stereological Analysis System (Olympus Danmark A/S, Glostrup, Den-
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cause there were no right/left asymmetries in the volume of the SCN, the
right and left hemispheres were sampled alternately for this estimation.
By applying the same stereological technique, the total number of SCN
astrocytes and the total numbers of AVP-, VIP-, GRP-, and SS-
immunoreactive neurons were estimated independently from appropri-
ately immunostained sections. The sampling schemes used were as de-
scribed above, with the following modiﬁcations. (1) Alternate sections
were used, which provided an average of 12 sections per nucleus; conse-
quently, the ssf was 0.5; (2) microscope ﬁelds were sampled using an
interframe distance of 0.048 mm (x-axis) by 0.046 mm ( y-axis); the area
of the counting frame used for astrocytes and for AVP- and VIP-
immunoreactive neurons was 840 mm
2, and hence the asf was 0.3804; for
GRP- and SS-immunoreactive neurons, the area of the counting frame
was 1036 mm
2 and thus the asf was 0.4692; (3) the disector had a ﬁxed
depth of 8 mm, and the tsf was 0.4; and (4) the ﬁnal magniﬁcation at the
level of the monitor was 33403. With use of these sampling schemes, an
average of 110 astrocytes, 100 AVP-immunoreactive cells, 70 VIP-
immunoreactive cells, 50 GRP-immunoreactive cells, and 20 SS-
immunoreactive cells were counted per nucleus. Cell counts were per-
Figure 1. A, Photomicrograph of the SCN from a Giemsa-stained glycolmethacrylate-embedded coronal section of the hypothalamus. The dorsolateral
boundary of the left SCN is indicated by arrowheads. Sections such as this were used to estimate the volume of, and the total number of neurons in, the
SCN. OC, Optic chiasm; F, fornix. Scale bar, 200 mm. B, High-power micrograph of neurons and glial cells of Giemsa-stained SCN. Arrowheads indicate
SCN neurons in which typical invaginations of the nuclear membrane can be visualized. Arrows indicate glial cells. Proﬁles such as these were not
considered for the estimation of the total number of neurons. Scale bar, 5 mm. C, Photomicrograph of a GFAP-immunostained section, counterstained
with cresyl violet, through the mid-SCN. The arrowheads indicate the dorsolateral boundary of the nucleus. Note the strong GFAP-immunoreactivity
displayed by the SCN relative to the adjacent hypothalamus. Scale bar, 50 mm. D, High magniﬁcation of GFAP-immunostained glial cells. Only structures
with morphological features and staining properties similar to these were considered for counting purposes. Scale bar, 10 mm.
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animal. Cytoplasmic GFAP immunoreactivity was the criterion for astro-
cyte identiﬁcation (Fig. 1D), and immunostaining of the perikaryal cyto-
plasm with a relatively unstained nucleus was the criterion for the
identiﬁcation of AVP-, VIP-, GRP-, and SS-containing neurons.
Semiquantitative analysis of autoradiograms
Autoradiographic signals from the SCN were digitized with a video
densitometer (Cybertech CS-1, Image Documentation System, Berlin,
Germany) and processed using the Cybertech Image Processing System
(Version 1.2, 1990). Unidimensional densitometry was used to integrate
and compare the optical densities of hybridization signals and for cor-
rection of the background. The quantiﬁcations were made on both sides
of the 12–20 autoradiographic images of the SCN obtained per animal.
The same hardware and software adjustments were applied in the control
and experimental animals. The values were expressed in arbitrary optical
density units.
Statistical analysis
A two-way ANOVA was performed on data from control and experimen-
tal groups analyzed after 6 and 12 months of treatment to discern the
main effects. Age and treatment were used as independent variables. A
two-way ANOVA was also applied to evaluate the effects of treatment
and time of day on serum corticosterone concentrations. To test for the
effect of treatment on the morphometric data obtained from immuno-
stained material and for the effect of time of day on blood alcohol
concentrations, a one-way ANOVA was performed. Animals were used
as replicates and the remainder mean square as the error term. Subse-
quent multiple comparisons were performed using post hoc linear poly-
nomial contrasts. Throughout the text, data are presented as means with
their coefﬁcients of variation (CV 5 SD/mean). Differences were consid-
ered to be signiﬁcant if p , 0.05. The coefﬁcient of error (CE) of the
individual estimates was calculated as shown by West et al. (1991).
RESULTS
Body and brain weights
The mean body and brain weights are presented in Table 1.
ANOVA showed that the variations in the body weights were
dependent on the effect of treatment (F(2,64) 5 21.78; p , 5 3
10
24). Eight- and 14-month-old control rats were signiﬁcantly
heavier than the age-matched pair-fed control and ethanol-
treated rats. No difference was found between the mean body
weights of pair-fed controls and ethanol-treated rats. In addition,
withdrawn rats weighed less than control rats, but they were
heavier than the age-matched ethanol-treated and pair-fed con-
trol rats. The animals from the 14-month-old groups were globally
heavier than those from the 8-month-old groups, but no signiﬁ-
cant effect of age was found (F(1,64) 5 3.42; p 5 0.069); likewise,
no interaction between age and treatment was detected (F(2,64) 5
1.35; p 5 0.267). No effects of age (F(1,64) 5 3.50; p 5 0.066) and
Figure 2. Diurnal variation of serum corticosterone concentrations in
control (f—f; n 5 6), ethanol-treated (F—F; n 5 7), and withdrawn
(—; n 5 7) rats. Symbols represent means, and error bars represent
SEM. Abscissa: time of experiment. For further details, see Results.
Figure 3. Graphic representation of the morphometric data obtained
from the SCN of control (C), pair-fed control (PFC), ethanol-treated
(ET), and withdrawn (W) rats after experimental periods of 6 months
(8-month-old animals) and 12 months (14-month-old animals). A, Volume
of the SCN. B, Total number of SCN neurons. C, Total number of
astrocytes in the SCN of 14-month-old rats. Horizontal bars represent
mean values.
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(Table 1).
Blood ethanol concentrations
The mean amount of ethanol consumed, calculated from all
ethanol-treated rats used in this study, was 9.0 gm/kg body weight
per day. Blood ethanol concentrations were lower in the evening
than in the morning (F(1,44) 5 285.66; p , 5 3 10
24), a ﬁnding
that is compatible with the observation that alcohol-treated rats
consume the available food at a constant rate during the dark
phase and almost ignore it during the light phase (Miller, 1992).
The values found ranged between 117 (0.04) and 91 (0.06) mg/dl
for the samples collected in the morning and in the evening,
respectively.
Corticosterone concentrations
In control animals, the serum corticosterone levels were lowest at
the beginning of the light phase and reached their highest values
at 8:00 P.M. (Fig. 2). In ethanol-treated rats, the highest concen-
tration was reached earlier, i.e., at 2:00 P.M., and the magnitude
of the diurnal variations was smaller than in controls (Fig. 2).
Although exposure to ethanol, either acutely (Ellis, 1966) or over
a short period (Tabakoff et al., 1978), has been reported to
increase the plasma levels of corticosterone, there is increasing
evidence that long-term exposure to ethanol might lead to an
adaptation of the hypothalamic-pituitary-adrenal axis (Spencer
and McEwen, 1990; Rivier, 1996). Our data are consistent with
this view, because we found that in rats consuming ethanol for 12
months, the mean serum corticosterone levels do not differ from
those of controls. Furthermore, no differences were found be-
tween the corticosterone concentrations of these groups and those
of rats withdrawn from alcohol for a period of 6 months. In
addition to showing that treatments had no effects on serum
corticosterone concentrations (F(2,67) 5 0.30; p 5 0.740), how-
ever, ANOVA revealed signiﬁcant ﬂuctuations in corticosterone
secretion, which were related to the time of day (F(3,67) 5 19.10;
p , 5 3 10
24) and a signiﬁcant interaction between treatment and
the diurnal variations in corticosterone concentrations (F(6,67) 5
2.29; p 5 0.044).
Volume of SCN
No signiﬁcant effects of treatment (F(2,30) 5 1.99; p 5 0.153) and
age (F(1,30) 5 0.01; p 5 0.994) on the volume of the SCN were
found (Fig. 3A), and there were no variations in the volume of the
SCN between ordinary controls and pair-fed controls. In the
experimental groups, the volumes of the SCN displayed a higher
mean relative variation among animals (CV 5 0.12) than in the
control groups (CV 5 0.10); the mean CE of the estimates
was 0.025.
Total number of neurons
The estimated numbers of neurons in the SCN of control, pair-fed
control, ethanol-treated, and withdrawn rats at the different ages
analyzed are shown in Figure 3B. No effects of treatment (F(2,30)
5 0.31; p 5 0.737) or age (F(1,30) 5 0.01; p 5 0.920) on the total
number of neurons were found. The mean CV of the neuronal
numbers was 0.11 in control rats, 0.13 in ethanol-treated rats, and
0.08 in withdrawn rats; the average CE of the estimates was 0.079.
Total number and relative proportion of astrocytes
The total numbers of astrocytes estimated on the basis of counts
of GFAP-positive cells in 14-month-old control and ethanol-
treated rats are shown in Figure 3C. The mean number of astro-
cytes did not vary between control and ethanol-treated rats (F(1,8)
5 1.48; p 5 0.258), and no qualitative differences were observed
in the morphology of the astrocytes between these groups. The
mean observed relative variation among animals was higher in the
ethanol-treated group (CV 5 0.16) than in the control group
(CV 5 0.12); the mean CE of the estimates was 0.057. Astrocytes
identiﬁed by immunostaining with antibody against GFAP (Big-
nami and Dahl, 1977; Morin et al., 1989) were estimated to
amount to ;10% of the number of neurons in the SCN, conﬁrm-
ing previous estimates from our laboratory (Madeira et al., 1995).
Other estimates based on quantitative ultrastructural observations
have suggested that the proportion of astrocytes is much higher,
amounting to 30% (Gu ¨ldner, 1983) or 65% (van den Pol et al.,
1992) of the number of neurons.
AVP-immunoreactive neurons
These neurons were concentrated in the dorsomedial division of
the SCN (Fig. 4), along its entire rostrocaudal extent, and most of
them had fusiform cell bodies with beaded neurites extending
from the poles of the cell bodies (Fig. 4G,H). In addition, the
plexus formed by AVP ﬁbers was also much denser in the dorso-
medial division of the SCN than in the adjacent ventrolateral
division, where ﬁbers were sparse (Fig. 4A–B). These ﬁndings are
compatible with previous observations made in the hamster (Card
and Moore, 1984) and in the rat (van den Pol and Tsujimoto,
1985). The distribution of AVP-immunoreactive neurons and
ﬁbers was identical in control, ethanol-treated, and withdrawn
rats, but the cell density and the staining intensity of the ﬁbers
within the nucleus and in its projection to the subparaventricular
zone appeared to be reduced in ethanol-treated and withdrawn
rats (Fig. 4C–F). The total number of AVP neurons in control rats
is 1773 (Fig. 4I). They therefore represent ;10% of the total
neuronal population of ;17,000, a smaller percentage than that
reported by Sofroniew and Weindl (1980), who found that AVP
neurons numbered 2055 in adult rats of a nonspeciﬁed strain and
accounted for 17% of all neurons. In other studies, the number of
AVP neurons has been estimated as 1137 (Brown Norway rats;
Roozendaal et al., 1987), 3176 (colchicine-treated Sprague Daw-
ley rats; Moore and Speh, 1993), and 1580 (Wistar rats; Swaab et
al., 1995).
ANOVA showed that the variations in the total number of
AVP-immunoreactive neurons were dependent on the effect of
treatment (F(2,15) 5 30.72; p , 5 3 10
24). When compared with
controls, the number of AVP neurons was reduced by 33% in
ethanol-treated rats and 39% in withdrawn rats; however, no
signiﬁcant difference was found between ethanol-treated and
withdrawn rats (Fig. 4I). The inter-animal CV was higher in the
experimental groups (CV 5 0.13) than in controls (CV 5 0.09);
the mean CE of the estimates was 0.042.
VIP-immunoreactive neurons
VIP derives from a precursor molecule, prepro-VIP, which after
cleavage also yields peptide histidine isoleucine and peptide his-
tidine valine (Nishizawa et al., 1987). Yet, VIP is present at a
higher concentration than these other peptides (Mikkelsen and
Fahrenkrug, 1994), and we therefore focused our analyses on
VIP-immunoreactive neurons (Fig. 5). These cells display a round
or elongate shape and give rise to one or two unbeaded processes
(Fig. 5G); they occupy the ventrolateral division of the SCN, and
the most ventrally located were frequently found to extend into
the optic chiasm (Fig. 5A). However, VIP-immunoreactive cell
bodies were not detected in the rostral and caudal extremities of
Madeira et al. · Ethanol Intake and SCN Peptide Expression J. Neurosci., February 15, 1997, 17(4):1302–1319 1307Figure 4. AVP immunoreactivity in the SCN of control (A, B), ethanol-treated (C, D), and withdrawn (E, F) rats. A, C, E, Photomicrographs of coronal
sections at mid-SCN levels. The box in A delineates the area shown at higher magniﬁcation in B. The corresponding areas in C and E are shown at higher
magniﬁcation in D and F, respectively. Densely stained AVP-immunoreactive neurons concentrated in the dorsomedial part of the nucleus project ﬁbers
dorsally (arrows) along the wall of the third ventricle. Note that the density of this projection is reduced in the ethanol-treated rat and in the withdrawn
rat. OC, Optic chiasm. Scale bars, 200 mm. B, D, F, Enlargements of the boxed area in A and corresponding areas in C and E. The ﬁelds illustrated have
been rotated so that the dorsolateral part of the delineated areas appears to the right of the micrographs in B, D, and F. The concentration of
AVP-immunoreactive neurons and the density of the plexus of ﬁbers is higher in the control rat (B) than in the ethanol-treated (Figure legend continues)
1308 J. Neurosci., February 15, 1997, 17(4):1302–1319 Madeira et al. · Ethanol Intake and SCN Peptide Expressionthe nucleus. The density of VIP-immunoreactive ﬁbers was high in
both divisions of the SCN (Fig. 5A,B), and ﬁbers could be visu-
alized throughout the entire extent of the nucleus. The distribu-
tion of cells and ﬁbers was similar in all groups analyzed, and
these observations are in keeping with previous studies in the
hamster (Card and Moore, 1984), mouse (Mikkelsen and Fahr-
enkrug, 1994), and rat (van den Pol and Tsujimoto, 1985). How-
ever, the staining intensity of the ﬁber plexus within the SCN and
in the projection coursing to the subparaventricular zone along
the wall of the third ventricle appeared to be lighter in ethanol-
treated and withdrawn rats than in controls (Fig. 5A-F). The total
number of VIP neurons in control SCN was 1180 (Fig. 5H),
representing ;7% of the total number of SCN neurons. In pre-
vious studies, using different morphometric methods, Chee et al.
(1988) found 1152–1657 VIP neurons in Brown Norway rats, and
Moore and Speh (1993) found 2081 such neurons in colchicine-
treated Sprague Dawley rats, which they estimated as represent-
ing 20–26% of the total number of neurons.
ANOVA revealed that treatment had a signiﬁcant effect on the
total number of VIP-immunoreactive neurons (F(2,15) 5 80.36;
p , 5 3 10
24). The mean number of VIP neurons was reduced by
34% in ethanol-treated rats; in addition, a further decrease of
47% in the mean number of VIP neurons was found in withdrawn
rats relative to ethanol-treated rats (Fig. 5H). Again, the interin-
dividual variation of this estimate was greater in experimental
groups (CV 5 0.20) than in controls (CV 5 0.07); the mean CE
of the estimates was 0.069.
GRP-immunoreactive neurons
Although GRP is possibly colocalized with VIP (Okamura et al.,
1986), there is evidence that these peptides are produced by
different sets of neurons of the ventrolateral division of the SCN
(van den Pol and Tsujimoto, 1985). It is known, furthermore, that
in these neurons the expression of circadian rhythms is modulated
by photic stimulation (Shinohara et al., 1993); however, whereas
VIP-immunoreactive neurons are activated during the dark phase,
GRP-immunoreactive neurons are activated during the light
phase (Shinohara et al., 1993). Because the processing of light
information is basically different in these two subpopulations, we
incorporated a separate analysis of GRP-synthesizing neurons in
this study (Fig. 6). GRP-containing cell bodies are present
throughout the SCN, with the exception of the most caudal and
the most rostral extremities of the nucleus, where only immuno-
reactive ﬁbers can be seen. Most of the GRP neurons are bipolar
in form, with ovoid cell bodies giving rise to a single beaded
process from each pole (Fig. 6G,H). In conﬁrmation of previous
observations of van den Pol and Tsujimoto (1985) and Mikkelsen
et al. (1991), in the rostral portion of the SCN the GRP neurons
are conﬁned to the ventral part of the nucleus, often abutting or
protruding into the optic chiasm, whereas more caudally, the cells
are scattered throughout the entire ventrolateral subdivision (Fig.
6A). The distribution of GRP neurons and ﬁbers was similar in
control and experimental groups, but the staining intensity ap-
peared to be reduced in ethanol-treated and withdrawn rats
(Fig. 6A-F).
Estimates of the total number of GRP-immunoreactive neurons
are shown in Figure 6I; such neurons represent ;4% of the total
neuronal population in the SCN. A signiﬁcant effect of treatment
on the total number of neurons was found (F(2,13) 5 16.58; p 5
3 3 10
24). The mean total number of neurons was 32% smaller in
ethanol-treated than in control rats and 26% smaller in withdrawn
than in ethanol-treated rats (Fig. 6I). The interindividual varia-
tion in the number of neurons was smaller in the experimental
groups (CV 5 0.13) than in controls (CV 5 0.20); the mean CE
of the estimates was 0.072.
SS-immunoreactive neurons
Neurons containing SS are believed to participate only in local
circuits within the SCN, modulating the activity of the AVP- and
VIP-containing neurons (Daikoku et al., 1992; Fukuhara et al.,
1994). The perikarya of SS-immunoreactive neurons were distrib-
uted throughout the rostrocaudal extent of the SCN but conﬁned
to its dorsomedial division (Fig. 7A,B), and they displayed an
ovoid or spherical shape (Fig. 7G,H). SS-immunoreactive ﬁbers
were present in the ventrolateral and dorsomedial divisions of the
SCN but did not extend outside its boundaries, a ﬁnding that is in
agreement with previous observations (Card and Moore, 1984;
van den Pol and Tsujimoto, 1985). The pattern of cell and ﬁber
distribution was similar in all groups analyzed, but the staining
intensity of SS-immunoreactive ﬁbers and the cell density were
apparently decreased in ethanol-treated and withdrawn rats (Fig.
7A-F). Our results show that among the speciﬁc subpopulations of
SCN neurons, SS-immunoreactive neurons are the least numer-
ous, representing only 1% of the total neuronal population in the
SCN. Treatment had a signiﬁcant effect on the total number of
SS-immunoreactive neurons (F(2,13) 5 7.17; p 5 0.008). The mean
number of neurons was 20% smaller in ethanol-treated than in
control rats, and 12% less in withdrawn than in ethanol-treated
rats (Fig. 7I). The mean CV was 0.08 in the control and 0.21 in the
experimental groups; the mean CE of the estimates was 0.078.
Neuropeptide mRNA expression
From the SCN subpopulations investigated, AVP- and VIP-
producing neurons were found to be the most abundant in the
dorsomedial and ventrolateral subdivisions of the SCN, respec-
tively. There is evidence, furthermore, that the circadian rhythm
of AVP mRNA expression is endogenously driven, whereas that
of VIP mRNA expression is entrained by photic stimuli (Uhl and
Reppert, 1986; Duncan et al., 1995). We therefore tested whether
AVP and VIP mRNA expression was altered by CET and, if so,
whether withdrawal from alcohol could reverse the alcohol-
induced alterations in peptide mRNA expression. As reported
previously (Card et al., 1988), AVP mRNA labeling was present in
the dorsomedial region of the SCN (Fig. 8A–C), whereas VIP
mRNA was detected in the ventrolateral region of the nucleus
(Fig. 8E–G). In control rats, there was a high expression of both
peptide mRNAs. Conversely, in ethanol-treated and withdrawn
rats, the hybridization signals were reduced dramatically for both
peptides. Comparisons of the steady-state AVP and VIP mRNA
signals between ethanol-treated and withdrawn rats revealed that
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(D) and withdrawn rats (F). The number of AVP-immunoreactive neurons is smaller and the ﬁber plexus less dense in the withdrawn rat than in the
ethanol-treated rat. Scale bars, 50 mm. G, A bipolar AVP-immunoreactive neuron with a beaded process (arrowhead) extending from the upper pole of
the perikaryon. Scale bar, 10 mm. H, Two intensely stained AVP-immunoreactive neurons with pale nuclei. A neurite arising from one pole of one of these
neurons is indicated (arrowhead). Scale bar, 10 mm. I, Graphic representation of the total number of AVP-immunoreactive neurons obtained from the
SCN of control (C), ethanol-treated (ET), and withdrawn (W) rats. Horizontal bars represent mean values. C versus ET, C versus W, p , 5 3 10
24.
Madeira et al. · Ethanol Intake and SCN Peptide Expression J. Neurosci., February 15, 1997, 17(4):1302–1319 1309Figure 5. VIP immunoreactivity in the SCN of control (A, B), ethanol-treated (C, D), and withdrawn (E, F) rats. A, C, E, Photomicrographs of coronal
sections through mid-SCN levels. The box in A delineates the area shown at higher magniﬁcation in B. The corresponding areas in C and E are shown
at higher magniﬁcation in D and F, respectively. VIP-immunoreactive neurons are conﬁned to the ventrolateral part of the nucleus, and some are
embedded in the optic chiasm (OC). A dense projection of VIP-immunoreactive ﬁbers (arrows) courses dorsally along the wall of the third ventricle. The
density of this projection is markedly reduced in the ethanol-treated rat (C) and still more in the withdrawn rat (E). Scale bars, 200 mm. B, D, F,
Enlargements of the boxed area in A and corresponding areas in C and E. The ﬁelds illustrated have been rotated, (Figure legend continues)
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ethanol-treated group (Fig. 8). Thus, steady-state in situ hybrid-
ization measurements of the mRNAs encoding AVP and VIP
strongly support the progressive reductions in AVP and VIP
immunoreactivity observed during CET and alcohol withdrawal.
DISCUSSION
Most of the investigations of structural alterations associated with
CET have been centered on the hippocampal formation and
cerebellar cortex because of the involvement of these regions of
the brain in cognitive functions and motor coordination, both of
which are markedly affected by CET (for reviews, see Walker et
al., 1981; Charness, 1993). Such studies have shown that the
morphological alterations induced by CET are primarily degen-
erative in nature and consist of reductions in the numbers of
neurons and synapses, changes in the size of neuronal cell bodies
and synaptic contacts, loss of dendritic branches and spines, and
disruption of cell organelles (Walker et al., 1981; Tavares et al.,
1983, 1987; McMullen et al., 1984; Paula-Barbosa and Tavares,
1985; Paula-Barbosa et al., 1986, 1993; Pentney and Quigley,
1987; Cadete-Leite et al., 1989; Bonthius and West, 1990, 1991).
Because neuroendocrine abnormalities are frequently associ-
ated with chronic alcohol exposure, the hypothalamus has long
been considered a probable target for alcohol; however, ap-
proaches to the study of the effects of alcohol on the hypothala-
mus have so far been mostly functional and have permitted very
little insight into the question of whether these disorders depend
on changes in hypothalamic structure. As far as we are aware, the
only morphological studies that address the effects of alcohol on
hypothalamic nuclei are our own studies of the supraoptic nucleus
of adult rats exposed to alcohol during periods of 12 and 18
months (Madeira et al., 1993; Ruela et al., 1994); in these studies
we showed that CET leads to the loss of 40% of the neurons of the
supraoptic nucleus and, paradoxically, to a marked enlargement
of the nucleus as a whole, as a result of the increase in the volume
of the surviving neurons and of the associated neuropil. We
suggested that the enlargement of the remaining neurons and of
the nucleus as a whole represented compensatory hypertrophy
induced by the neuronal loss.
In this study we present evidence that CET, despite the marked
alterations it induces in functions modulated by the SCN, does not
cause major anatomical changes in this nucleus. Speciﬁcally, we
found that the total number of neurons and the volume of the
SCN are identical in control and ethanol-treated rats, regardless
of the duration of alcohol consumption. It could be argued that
the absence of change in total cell numbers might be the net result
of a decrease in the number of neurons and a parallel increase in
the number of astrocytes, but our results allow us to eliminate this
possibility because the total number of GFAP-immunoreactive
cells is identical in control and ethanol-treated rats. Likewise, the
components of the neuropil, predominantly the neurites of SCN
cells, are probably not altered signiﬁcantly by CET, as can be
inferred from the absence of variations in total cell numbers and
from the unchanging volume of the SCN between control and
ethanol-treated rats.
We can therefore conclude that the neurotoxic effects of alco-
hol are not uniform throughout the hypothalamus, because in
contrast to the magnocellular neurons of the supraoptic nucleus
(Madeira et al., 1993), the parvocellular neurons of the SCN are
remarkably resistant to its effects. This ﬁnding was not entirely
unexpected, because there is compelling evidence that excitotox-
icity, which is the most probable mechanism underlying alcohol-
induced neurodegeneration (Lovinger, 1993), was not observed in
the SCN after exposure to kainic acid (Peterson and Moore, 1980)
or high concentrations of glutamate (Meijer et al., 1993; Ding et
al., 1994). Nonetheless, excitotoxic mechanisms might be involved
in responses to CET in the retinorecipient area of the SCN
because of evidence that (1) in CET there is both decreased
activation of GABAA receptors and enhanced glutamatergic ac-
tivity (attributable to upregulation of NMDA receptors) (for
reviews, see Hunt, 1993; Lovinger, 1993; Korpi, 1994) and (2) the
excitation evoked in SCN cells by glutamate, almost certainly the
primary neurotransmitter of the retinohypothalamic tract (van
den Pol and Dudek, 1993; Morin, 1994), is mediated by the same
subtype of glutamate receptor (Mikkelsen et al., 1993; Gannon
and Rea, 1994), although AMPA and metabotropic receptors
might also be involved (Mick et al., 1995).
Several factors might have accounted for the absence of CET-
induced NMDA-mediated toxicity. First, there is increasing evi-
dence that the sensitivity of neuronal populations to alcohol
depends on the receptor speciﬁcity of the cells, and SCN neurons
express the NR1 and NR2C subunits of NMDA receptors
(Mikkelsen et al., 1993; Gannon and Rea, 1994) but not the
subunits modiﬁed by CET, i.e., the NR2A and NR2B subunits
(Hu et al., 1996). With respect to GABAA receptors, they contain
the a2, a3, a5, and g2 subunits (Gao et al., 1995), and the available
data indicate that CET decreases the levels of the a2 and a5
subunits but does not alter the expression of the a3 subunit
(Korpi, 1994), the most abundant in the SCN neuropil (Gao et al.,
1995), where most of the GABAergic synapses are established
(Decavel and van den Pol, 1990). In addition, SCN cells contain
high levels of the GluR2 subunit of the AMPA receptor (Gannon
and Rea, 1994), which might provide additional protection against
CET-induced NMDA-mediated toxicity, because there is evi-
dence that in heteromeric AMPA receptors the Ca
21-
impermeability of GluR2 is dominant (Jonas et al., 1994). Second,
several lines of evidence indicate that serotonin, an abundant
neurotransmitter in the retinorecipient area of the SCN produced
by neurons of the raphe nuclei (van den Pol and Tsujimoto, 1985;
Morin, 1994), modulates retinohypothalamic-mediated glutama-
tergic neurotransmission by lowering the extracellular concentra-
tion of glutamate (Selim et al., 1993; Srkalovic et al., 1994). CET
enhances serotonin release in several regions of the brain (Hunt,
1993), and should this phenomenon occur in the SCN, the avail-
ability of glutamate might be decreased by CET. Third, our results
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and the dorsolateral part of the delineated areas appears to the right of the micrographs in B, D, and F. VIP-immunoreactive neurons and ﬁbers appear
in highest densities in the control rat (B); in the ethanol-treated rat (D), and particularly in the withdrawn rat (F), cell and ﬁber densities are markedly
reduced. Scale bars, 50 mm. G, A cluster of neurons immunoreactive for VIP. In those located in the top part of the micrograph, stained cytoplasm and
pale nuclei can be seen, whereas the neuron at the bottom is so heavily immunostained that the nucleus cannot be visualized. Smooth processes
(arrowheads) arise from all neurons. Scale bar, 10 mm. H, Graphic representation of the total number of VIP-immunoreactive neurons obtained from the
SCN of control (C), ethanol-treated (ET), and withdrawn (W) rats. Horizontal bars represent mean values. C versus ET, C versus W, ET versus W, p ,
5 3 10
24.
Madeira et al. · Ethanol Intake and SCN Peptide Expression J. Neurosci., February 15, 1997, 17(4):1302–1319 1311Figure 6. GRP immunoreactivity in the SCN of control (A, B), ethanol-treated (C, D), and withdrawn (E, F) rats. A, C, E, Photomicrographs of coronal
sections through mid-SCN levels. The box in A delineates the area shown at higher magniﬁcation in B. The corresponding areas in C and E are shown
at higher magniﬁcation in D and F, respectively. GRP-immunoreactive cell bodies are concentrated in the ventrolateral part of the nucleus, and some are
embedded in the optic chiasm (OC). GRP-immunoreactive ﬁbers (arrows) course dorsally, adjacent to the third ventricle wall. Scale bars, 200 mm. B, D,
F, Enlargements of the boxed area in A and corresponding areas in C and E. The ﬁelds illustrated have been rotated so that the dorsolateral part of the
delineated areas appears to the right of the micrographs in B, D, and F. In the control rat (B), a high concentration of (Figure legend continues)
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the normal astrocyte-to-neuron ratio. This fact is of the utmost
importance for the protection of the SCN against the toxic effects
of ethanol, because there is evidence that SCN astrocytes can
modulate extracellular ion levels in response to glutamate and
serotonin (van den Pol et al., 1992). Finally, SCN neurons express
high levels of nerve growth factor (NGF) receptor immunoreac-
tivity (Kiss et al., 1993) and contain both NGF and its precursor
(Senut et al., 1990; Bina and Rusak, 1991). That the presence of
neurotrophic factors might counteract the toxic effects of ethanol
is suggested by in vivo (Walker et al., 1993) and in vitro studies
(Heaton et al., 1993), which show that NGF reduces the toxic
effects of ethanol and protects neurons from glutamate-induced
excitotoxicity.
Given that neuronal numbers in SCN do not fall as a conse-
quence of CET, we considered the possibility that changes in the
peptide expression of SCN neurons might provide an explanation
for the alcohol-induced disruption of circadian rhythms. Our
ﬁndings indicate a substantial CET-induced loss in the numbers of
neurons producing AVP, VIP, GRP, and SS. A possible explana-
tion for the reductions in these neuronal populations is cell death,
a hypothesis that our data do not corroborate because they
establish that there is no reduction in total neuronal number in
the SCN as a result of CET. It should be said, however, that our
estimates of total neuron numbers in ethanol-treated rats cannot
completely negate such a possibility. Because of the large varia-
tion in neuron numbers among ethanol-treated rats (13%), we
theoretically may have failed to detect small losses in the sub-
populations of the SCN amounting to an overall loss of 7.6% of
the total number of neurons. However, AVP-, VIP-, GRP-, and
SS-immunoreactive neurons together represent only 22% of the
total neuronal population of the SCN, and there is no reason to
assume that the remaining neurons (78% of the total neurons)
would not also be vulnerable to the effects of chronic alcohol
exposure. In fact, studies performed in other regions of the brain
(Lescaudron et al., 1986) have shown that GABA neurons, which
represent the most abundant subpopulation in the SCN and are
equally distributed in the dorsomedial and ventrolateral divisions
of the nucleus (Moore and Speh, 1993), are also markedly vul-
nerable to the toxic effects of ethanol. Furthermore, the ﬁnding
that in withdrawn rats the overall loss of AVP-, VIP-, GRP-, and
SS-immunoreactive neurons is 9% of the total neurons and that
the observed interindividual variance in the estimations of total
neuron numbers is smaller (8%) and no cell loss was observed,
allows us to conclude that cell death is deﬁnitely not the major
underlying factor of the reductions observed in the subpopula-
tions analyzed. Therefore, they must depend on decreased syn-
thesis of the identifying peptides or on increased axonal transport
and/or release of the peptides. The latter possibilities are unlikely
because CET has been shown in previous studies to result in
reduced rates of fast axonal transport in (McLane, 1987) and of
neuropeptide release from these cells (Wang et al., 1991) and in
disruption and loss of microtubules (Paula-Barbosa and Tavares,
1985), on which rapid axon transport depends. We therefore favor
the possibility that the reduction in the number of neuropeptide-
containing neurons is a consequence of reduced synthesis, and this
interpretation is strengthened by our observation that mRNAs for
two of these peptides, AVP and VIP, appear to be downregulated
in CET (weaker hybridization signals).
Several mechanisms can be involved to explain CET-induced
depression of neuropeptide synthesis. First, ethanol-treated rats
have high levels of circulating corticosterone and low levels of
circulating testosterone (Ellis, 1966; Tabakoff et al., 1978; Cicero
et al., 1979), and there is evidence that glucocorticoids inﬂuence
AVP synthesis (Davis et al., 1986) and gonadal steroids modulate
the expression of AVP, VIP, and SS (for review, see Madeira and
Lieberman, 1995). The alterations we found, however, are not
likely to be causally related to these hormonal effects, because
glucocorticoids do not interfere with AVP synthesis in the SCN
(Davis et al., 1986) and SCN neurons do not contain glucocorti-
coid receptors (Cintra et al., 1994) or receptors for gonadal
steroids (Simerly et al., 1990; Zhou et al., 1994). Second, CET
affects virtually all known neurotransmitter systems in the brain
(Shanley and Wilce, 1993; De Witte, 1996) and might therefore
lead to changes in the interactions between SCN neurons and
their afferents. This hypothesis is suggested by the observation
that selective deafferentation of the SCN, either by loss of reti-
nohypothalamic ﬁbers (Laemle, 1992) or destruction of its sero-
toninergic input (Kawakami et al., 1994), leads to signiﬁcant
reductions in the number of VIP-immunoreactive neurons, the
main targets of these afferents (Morin, 1994). The reduction in the
number of VIP-immunoreactive neurons detected in our study
suggests that CET might alter the balance between the excitatory
and the inhibitory inputs to the retinorecipient area of the SCN
and favor the latter. The fact that availability of presynaptic
GABA, the most abundant neurotransmitter in the SCN (Decavel
and van den Pol, 1990; Moore and Speh, 1993; Morin, 1994; Buijs
et al., 1995), is not altered by CET (Frye and Fincher, 1988;
Tremwel et al., 1994) lends support to this possibility. The ﬁnding
of a similar reduction in the total number of neurons of every
subpopulation analyzed does not negate this possibility, because
the complex intrinsic connectivity of the SCN (Daikoku et al.,
1992; van den Pol and Dudek, 1993) implies that changes in
neurons of the retinorecipient area might impinge on the activity
of neurons in its ventromedial division. Third, alcohol could
interfere with protein synthesis, either in a direct way by decreas-
ing mRNA synthesis and translation (Tewari and Noble, 1979) or
the rate of polypeptide elongation (Peters and Steele, 1982), or
indirectly by interfering with secondary messenger systems (Hunt,
1993) or by reducing normal neurotrophic inﬂuences (Walker et
al., 1993). The view that CET might directly disrupt cellular
metabolism in the SCN is strengthened by the striking similarities
between the alterations induced by this condition and those at-
tributable to aging. These include a decrease in the number of
AVP- and VIP-immunoreactive neurons (Roozendaal et al., 1987;
Chee et al., 1988), reduction in neurotransmitter levels (Amenta
et al., 1991) and in RNA and protein synthesis (Finch and Mor-
gan, 1990), and changes in intracellular transcription factors reg-
4
GRP-immunoreactive neurons and ﬁbers is seen in the ventrolateral part of the SCN. The densities of the neurons and ﬁber plexus are markedly reduced
in the ethanol-treated rat (D); the reduction is even more evident in the withdrawn rat (F), which shows the lowest densities of cell bodies and ﬁbers.
Scale bars, 50 mm. G, A GRP-immunoreactive neuron with an intensely stained cytoplasm, a pale nucleus, and a process (arrowhead) arising from its
inferior pole. Scale bar, 10 mm. H, Two GRP-immunoreactive neurons. Processes (arrowheads) can be seen originating from one of the neurons. Scale
bar, 10 mm. I, Graphic representation of the total number of GRP-immunoreactive neurons obtained from the SCN of control (C), ethanol-treated (ET),
and withdrawn (W) rats. Horizontal bars represent mean values. C versus W, p , 5 3 10
24; C versus ET, p , 0.001; ET versus W, p , 0.05.
Madeira et al. · Ethanol Intake and SCN Peptide Expression J. Neurosci., February 15, 1997, 17(4):1302–1319 1313Figure 7. SS immunoreactivity in the SCN of control (A, B), ethanol-treated (C, D), and withdrawn (E, F) rats. A, C, E, Photomicrographs of coronal
sections through mid-SCN levels. The box illustrated in A delineates the area shown at higher magniﬁcation in B. The corresponding areas in C and E
are shown at higher magniﬁcation in D and F, respectively. SS-immunoreactive ﬁbers are conﬁned to the SCN, but clusters of SS-immunoreactive neurons
(arrows) can be seen in the periventricular zone of the hypothalamus. OC, Optic chiasm. Scale bar, 200 mm. B, D, F, Enlargements of the boxed area in
A and of the corresponding areas in C and E, in the same orientation. The cell bodies (arrows) are conﬁned to the dorsomedial subdivision of the SCN,
where SS-immunoreactive ﬁbers are also concentrated. The number of SS-immunoreactive neurons and the density of (Figure legend continues)
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ity that the alterations found in peptide synthesis and
immunoreactivity in the SCN of ethanol-treated rats might simply
be a consequence of CET-induced disruption of their daily
rhythms cannot be ignored, because the brains used in this study
for the immunocytochemical and in situ hybridization analyses
were collected at the same time each day, whereas it is known that
the mRNAs and peptides analyzed in our study undergo signiﬁ-
cant circadian changes, particularly between the hours of darkness
and light (Inouye and Shibata, 1994). These changes are different,
however, for each peptide, and for each peptide there is also a
different and speciﬁc time lag between the peak level of mRNA
expression and the peak peptide content (Inouye and Shibata,
1994). Thus if the changes we have found in mRNA levels and in
the numbers of immunoreactive neurons were attributable pri-
marily to a CET-induced disruption in the normal daily rhythms
of peptide expression, we would not expect to see either a uniform
reduction in these parameters or a similar pattern of change in
mRNA levels and numbers of immunoreactive neurons for each
of the peptides examined.
If the neurochemical alterations observed during CET were
simply to be a consequence of the preponderance of inhibitory
versus excitatory inputs on the SCN, one would expect that after
withdrawal from alcohol the neurochemistry of the SCN would be
restored and the protein synthesis resumed, because under these
conditions excitatory neurotransmission would override the inhib-
itory inﬂuences (Lovinger, 1993). Data obtained from withdrawn
rats refute this explanation, however, because we found that
despite the absence of alterations in the volume and in the total
number of neurons, withdrawal leads to a further decay in the
total number of AVP, VIP, GRP, and SS neurons. These alter-
ations are attributable to a more serious depression of protein
synthesis, because we also show that AVP and VIP mRNA levels
decrease further in withdrawn rats than in ethanol-treated rats.
These data demonstrate that CET irreversibly damages SCN
neurons and that withdrawal represents an additional insult for
the SCN, probably because neuronal metabolism had adapted to
high levels of ethanol, and withdrawal forces the neurons to make
a further major readjustment in their metabolism.
There is evidence that alcohol does not act as a nonspeciﬁc
depressant of protein synthesis; more speciﬁcally, it has been
reported that although exposure to ethanol for 1 or 2 weeks
decreases AVP mRNA levels in several extrahypothalamic and
hypothalamic nuclei (Ishizawa et al., 1990; Gulya et al., 1991;
Sanna et al., 1993), including the SCN, after longer periods of
alcohol consumption both the synthesis and the content of AVP
Figure 8. Photomicrographs of hybridization signals from the SCN for AVP (A–C) and VIP (E–G) from representative autoradiograms of control (A,
E), ethanol-treated (B, F), and withdrawn (C, G) rats. AVP and VIP mRNAs are reduced in the ethanol-treated and withdrawn rats. The withdrawn rat
shows the weakest signals for AVP and VIP. D, H, Graphic representations of the steady-state levels of mRNAs coding for AVP (D) and VIP (H)i n
control (C), ethanol-treated (ET), and withdrawn (W) rats. The values are expressed as arbitrary optical density (O.D.) units. Columns represent means,
and vertical bars represent 1 SD. No statistical analysis was performed on this quantitative data because of the small number of rats analyzed (controls,
n 5 3; ethanol-treated, n 5 2; withdrawn, n 5 2).
4
SS-immunoreactive ﬁbers are higher in the control (B) than in the ethanol-treated rat (D). Note that the cell and ﬁber densities are lower in the withdrawn
rat (F) than in the ethanol-treated rat. Scale bars, 50 mm. G, A cluster of round- and ovoid-shaped, darkly staining GRP-immunoreactive neurons. Scale
bar, 10 mm. H, A GRP-immunoreactive neuron with intensely immunostained cytoplasm and a pale nucleus; a neurite extends from its upper pole
(arrowhead). Scale bar, 10 mm. I, Graphic representation of the total number of SS-immunoreactive neurons obtained from the SCN of control (C),
ethanol-treated (ET), and withdrawn (W) rats. Horizontal bars represent mean values. C versus W, p , 0.0025; C versus ET, p , 0.01.
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et al., 1994; Carmona-Calero et al., 1995). That alcohol exposure
does not lead to a global depression of protein synthesis is further
supported by reports showing that after 1 or 4 weeks of alcohol
exposure, the mRNA levels of corticotropin releasing hormone
and thyrotropin releasing hormone are increased in the paraven-
tricular nucleus (Rivier et al., 1990; Zoeller et al., 1996), such as
what has been described for prodynorphin mRNA levels in the
hypothalamus (Gulya et al., 1993). Therefore, our data indicate
that SCN neurons are a speciﬁc target for alcohol, the effects of
which are manifested by changes in intracellular metabolism.
Furthermore, it may be that the mechanisms underpinning the
effects of alcohol withdrawal on SCN neurons are identical to
those leading to excitotoxic neurodegeneration in other regions of
the brain (McMullen et al., 1984; Phillips and Cragg, 1984;
Cadete-Leite et al., 1988, 1990; Paula-Barbosa et al., 1993). For
reasons similar to those advanced in relation to the effects of CET
on the retinorecipient area of the SCN, this proposal receives
additional support from the ﬁnding that the withdrawal-associated
alterations are particularly marked in the VIP-containing neu-
rons. However, as a result of various protective factors (men-
tioned above), the toxic effects might not be severe enough to
cause cell death but would be sufﬁcient to produce irreversible
metabolic damage.
Although the present study leaves open the question of whether
CET and withdrawal interfere with the clock mechanism itself, it
provides an insight into the effects of ethanol on biological
rhythms. The central role of the SCN in the generation of circa-
dian rhythms is well documented, and at least two of the neu-
ropeptides studied here, AVP and VIP, have been implicated in
circadian signaling from the SCN to various regions of the brain
that are ultimately responsible for the manifestation of behavioral
and physiological rhythms. In this study, we used measurements of
a robust rhythm, that of corticosterone secretion, to evaluate to
what extent CET and alcohol withdrawal inﬂuence the diurnal
rhythms in the SCN, particularly that of AVP production. The
AVP released by SCN neurons exerts inhibitory inﬂuences on the
synthesis of corticotropin releasing hormone (Kalsbeek et al.,
1992). This relationship has been suggested by the observation
that the high levels of AVP released from SCN terminals during
the light period coincide with the basal plasma levels of cortico-
sterone (Kalsbeek et al., 1996), and by experimental studies,
which show that the administration of AVP antagonists or lesions
of the SCN result in elevated basal levels of corticosterone in the
daytime, during the period when AVP is released from SCN
neurons (Kalsbeek et al., 1992, 1996). In light of these data, our
observation that the circulating levels of corticosterone were not
markedly inﬂuenced in any of the treatment groups is surprising,
because our immunohistochemical and mRNA hybridization
studies show that the activity of SCN neurons is markedly reduced
during CET and diminishes further after ethanol withdrawal. This
ﬁnding is compatible, however, with the view that AVP released
from the SCN is not the sole factor accounting for the plasma
level of corticosterone. Thus, animals with bilateral lesions of the
SCN do not display a continuously high plasma concentration of
this hormone (Kalsbeek et al., 1992), and adaptive changes occur
in the hypothalamic-pituitary-adrenal axis during CET leading to
the development of various degrees of tolerance to ethanol (Spen-
cer and McEwen, 1990; Rivier, 1996). However, the ﬁnding that
corticosterone levels peak earlier in ethanol-treated rats than in
control and withdrawn rats suggests that the circadian rhythms of
synthesis and content of SCN peptides (speciﬁcally AVP) are
likely to be altered by CET, albeit reversibly. In contrast to the
mild functional repercussions of the decreased activity of AVP-
producing neurons, the alterations induced by CET in reproduc-
tive functions and in the circadian pattern of locomotor activity
are compatible with the reductions we found in the synthesis and
immunoreactivity of VIP. In effect, several studies have shown
that decreases in VIP synthesis and release, brought about either
by exposure to constant light or as a result of lesions of the SCN,
lead to persistent estrous and to a disrupted circadian pattern of
locomotor activity (Stobie and Weick, 1990; Aguilar-Roblero et
al., 1994; Sollars and Pickard, 1995), alterations that are identical
to those observed during CET.
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